• Mashup Score: 1

    The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that empagliflozin does not provide any benefit for patients hospitalised with COVID-19. The results of the empagliflozin evaluation are published on medRxiv and will be submitted to a leading peer-reviewed medical journal. The RECOVERY trial is the world’s largest randomised clinical trial of potential treatments for…

    Tweet Tweets with this article
    • 4,263 patients COVID-19 There was no significant difference in the primary outcome of death within 28 days in either group (14% in the empagliflozin group compared with 14% in the usual care alone group). RECOVERY trial https://t.co/eVEG2UNvXW

  • Mashup Score: 1

    The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory drug normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19. The benefit was in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments which have previously been shown to…

    Tweet Tweets with this article
    • RT @DrPujaMehta1: Finally...hey👋 Team @recovery_rs @MartinLandray https://t.co/oW0L04774I Can you change the pic plse💊🙏 Bari std dose is…

  • Mashup Score: 1
    Welcome - 2 year(s) ago

    This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.

    Tweet Tweets with this article
    • And if you unfortunately end up hospitalised with COVID, please ask your NHS clinical team about participating in the RECOVERY trial and @HEAL_COVID (COI - I am CI of HEAL) https://t.co/7aidClEatc

  • Mashup Score: 5
    Welcome - 2 year(s) ago

    This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.

    Tweet Tweets with this article
    • The randomized platform https://t.co/fJveKv3LoS finds a 3rd repurposed drug ⬇️ mortality in people w/ #COVID19. Reminder to us all: well-designed, adeq powered RCTs may take more time, money, & pts to conduct, but they move fields forward. #MedTwitter https://t.co/U7OjPxPUNV

  • Mashup Score: 20

    The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that baricitinib, an anti-inflammatory drug normally used to treat rheumatoid arthritis, reduces the risk of death when given to hospitalised patients with severe COVID-19. The benefit was in…

    Tweet Tweets with this article
    • Fabulous confirmatory RECOVERY trial from UK of 8,156 patients shows #Baricitinib gave a 13% reduction in death for severe #COVID as compared to usual care  including steroids, tocilizumab & remdesivir. https://t.co/N5Mtj4gNho https://t.co/f3NSASpwN8 https://t.co/LvgmKFIQCU

  • Mashup Score: 0
    Welcome - 2 year(s) ago

    This national clinical trial aims to identify treatments that may be beneficial for adults hospitalised with confirmed COVID-19.

    Tweet Tweets with this article
    • To highlight just a few examples: @CovidGenomicsUK @GenomiccStudy @CCPUKstudy @TrialPrinciple @LivAgile @PROTECT_CCTU @HEAL_COVID @remap_cap https://t.co/l8LFI3ExJp 3/15